These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 36481435)

  • 41. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.
    Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K
    J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A descriptive study of Parkinson disease and atypical parkinsonisms in the Annuals of the Pathological Autopsy Cases in Japan.
    Horimoto Y; Sato C; Anan C; Suzuki A; Inagaki A; Tajima T; Hibino H; Inagaki H
    Neuropathology; 2023 Aug; 43(4):297-305. PubMed ID: 36336970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease.
    De Bartolo MI; Vivacqua G; Belvisi D; Mancinelli R; Fabbrini A; Manzo N; Costanzo M; Leodori G; Conte A; Fabbrini G; Morini S; Berardelli A
    Ann Neurol; 2023 Mar; 93(3):446-459. PubMed ID: 36385395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson's disease from atypical Parkinsonian syndromes.
    Sciacca G; Mostile G; Disilvestro I; Donzuso G; Manna R; Portaro G; Rascunà C; Salomone S; Drago F; Nicoletti A; Zappia M
    J Neurol; 2020 Jun; 267(6):1859-1863. PubMed ID: 32394017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
    Hall S; Janelidze S; Surova Y; Widner H; Zetterberg H; Hansson O
    Sci Rep; 2018 Sep; 8(1):13276. PubMed ID: 30185816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy.
    Huang SY; Chen SF; Cui M; Zhao M; Shen XN; Guo Y; Zhang YR; Zhang W; Wang HF; Huang YY; Cheng W; Zuo CT; Dong Q; Yu JT
    Mov Disord; 2023 Apr; 38(4):676-682. PubMed ID: 36781585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CSF α-synuclein does not differentiate between parkinsonian disorders.
    Aerts MB; Esselink RA; Abdo WF; Bloem BR; Verbeek MM
    Neurobiol Aging; 2012 Feb; 33(2):430.e1-3. PubMed ID: 21236518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis across a cohort of "atypical" atypical and complex parkinsonism.
    Malaquias MJ; Igreja L; Nogueira C; Pereira C; Vilarinho L; Quelhas D; Freixo JP; Oliveira J; Magalhães M
    Parkinsonism Relat Disord; 2023 Jun; 111():105408. PubMed ID: 37105015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Kaiserova M; Chudackova M; Prikrylova Vranova H; Mensikova K; Kastelikova A; Stejskal D; Kanovsky P
    Neurodegener Dis; 2021; 21(1-2):30-35. PubMed ID: 34695830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
    Dickson DW
    J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Atypical Parkinson's syndrome in old age].
    Iglseder B; Lange R
    Z Gerontol Geriatr; 2022 Aug; 55(5):421-430. PubMed ID: 35748931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.